My watch list
my.bionity.com  
Login  
NEWS
Current news

Deciphering diabetes with "game-changing" human blood vessels from stem cells

18-Jan-2019 Changes in blood vessels are the major cause of death and morbidity in diabetes. For the first time, scientists managed to grow perfect human blood vessels as organoids in a petri dish. This breakthrough engineering technology dramatically advances research of vascular dysfunction in diseas ... more

Novel materials convert visible into infrared light

Penetrate of living tissue and other materials without damage by high-intensity light exposure

18-Jan-2019 Columbia University scientists, in collaboration with researchers from Harvard, have succeeded in developing a chemical process to convert visible light into infrared energy, allowing innocuous radiation to penetrate living tissue and other materials without the damage caused by high-intens ... more

From gut to space

Candida albicans exploits lack of oxygen to cause disease

18-Jan-2019 Scientists from Umeå university have shown how the yeast Candida albicans can modulate and adapt to low oxygen levels in different body niches to cause infection and to harm the host. Studying adaption to hypoxic or anoxic niches is particularly fruitful, since it helps us to understand the ... more

SCHOTT to invest 300 million euros in pharmaceutical packaging business

Group to build new production facilities in Germany and China and expand capacity in India and Switzerland

18-Jan-2019 The SCHOTT technology group is set to invest around 300 million euros in the next three years in the expansion of its core business of glass tubing as the starting material for pharmaceutical packaging as well as pharmaceutical packaging made of glass and polymer, reinforcing its strong bel ... more

CRISPR/Cas9 shown to limit impact of certain parasitic diseases

Limiting the impact of schistosomiasis and liver fluke infection

17-Jan-2019 For the first time, researchers at the George Washington University (GW), together with colleagues at institutes in Thailand, Australia, the U.K. and the Netherlands, and more, have successfully used the gene-editing tool CRISPR/Cas9 to limit the impact of parasitic worms responsible for sc ... more

Velcro for human cells

Researchers engineer cellular adhesion receptors that can be controlled with light

17-Jan-2019 The ability of cells to adhere to each other and to their environment is the basis for multicellular life. Adhesion occurs via diverse receptors at the surface of cells that bind to specific ligands in their surroundings. Despite the importance of these adhesion receptors, there is a paucit ... more

Merck Welcomes Ten New Startups to its Innovation Center

17-Jan-2019 Merck announced the ten startups that will be joining the seventh intake of its Accelerator program at the Merck Innovation Center in Darmstadt. The teams come from nine different countries, making 2019 the most international intake in the Merck Accelerator’s history. They were chosen from ... more

Engineered T cells promote long-term organ transplant acceptance

16-Jan-2019 Organ transplant rejection is a major problem in transplantation medicine. Suppressing the immune system to prevent organ rejection, however, opens the door to life-threatening infections. Researchers at the University of Basel’s Biozentrum have now discovered a molecular approach preventin ... more

Stem Cells Regulate Their Fate by Altering Their Stiffness

Doing More with Less

16-Jan-2019 In adults, mesenchymal stems cells (MSCs) are primarily found in bone marrow and they play a vital role in repair of damaged organs. The transformation of a single MSC into complex tissue like cartilage and bone starts with its association with other MSCs in order to form microscopic cluste ... more

Gaining control over soft-molecule synthesis

16-Jan-2019 By gaining control over shape, size and composition during synthetic molecule assembly, researchers can begin to probe how these factors influence the function of soft materials. Finding these answers could help advance virology, drug delivery development and the creation of new materials. ... more

All news

Utilizing CRISPR for better antibiotics

Drug screening with Mobile-CRISPRi

15-Jan-2019 A University of Wisconsin-Madison researcher and his collaborators at the University of California, San Francisco have repurposed the gene-editing tool CRISPR to study which genes are targeted by particular antibiotics, providing clues on how to improve existing antibiotics or develop new o ... more

Turbocharger for the cell machinery

14-Jan-2019 The classic molecular-biological narrative has a simple form: Gene-RNA-protein. This is what we learned in school: DNA is transcribed into RNA. In the protein factories (the so-called ribosomes), the RNA serves as a kind of punch card - the proteins are assembled by the machinery exactly ac ... more

Chirality in 'real-time'

Circular dichroism in the deep ultraviolet

11-Jan-2019 In nature, certain molecules with the same chemical composition, can exist in two different shapes that are mirrors images of each other, much like our hands. This property is known as "chirality" and molecules with different chirality are called enantiomers. Enantiomers can exhibit entirel ... more

New fuel-delivery route for cells identified

Findings shed light on chronic diseases, aging

10-Jan-2019 Scientists at Washington University School of Medicine in St. Louis have identified a previously unknown route for cellular fuel delivery, a finding that could shed light on the process of aging and the chronic diseases that often accompany it. With age, cells gradually lose their ability t ... more

An errant editing enzyme promotes tumor suppressor loss and leukemia propagation

08-Jan-2019 Researchers at University of California San Diego School of Medicine report that detection of "copy editing" by a stem cell enzyme called ADAR1, which is active in more than 20 tumor types, may provide a kind of molecular radar for early detection of malignancies and represent a new therape ... more

Imaging nerve-cell interactions

04-Jan-2019 A new imaging technique developed by LMU researchers is garnering lots of attention. Based on a method for making tissues, organs and even whole organisms transparent, it promises to transform studies of the nervous system in particular. A new bioimaging technology provides unprecedented in ... more

Progress in Super-Resolution Microscopy

20-Dec-2018 Does expansion microscopy deliver true-to-life images of cellular structures? That was not sure yet. A new publication shows for the first time that the method actually works reliably. Immersing deeper and deeper into cells with the microscope. Imaging the nucleus and other structures more ... more

3.3 million euros for PreOmics

19-Dec-2018 PreOmics develops and produces innovative technologies for the pre-analytics of samples for mass spectrometry. Today, the processing of samples for mass spectrometry is usually carried out according to homemade protocols. These processes are slow, not reproducible, not robust and cannot be ... more

Oculyze & BIOTECON Diagnostics sign strategic partnership

18-Dec-2018 Oculyze and BIOTECON Diagnostics announced the signing of a strategic partnership. The agreement signed at the corporate offices of BIOTECON Diagnostics in Potsdam, appoints the Company as the exclusive global distributor of Oculyze’s latest technological innovation the Oculyze Better Brewi ... more

A new molecular player involved in T cell activation

13-Dec-2018 When bacteria or viruses enter the body, proteins on their surfaces are recognized and processed to activate T cells, white blood cells with critical roles in fighting infections. During T-cell activation, a molecular complex known as the microtubule-organizing center (MTOC) moves to a cent ... more

All news on bioanalytics

From gut to space

Candida albicans exploits lack of oxygen to cause disease

18-Jan-2019 Scientists from Umeå university have shown how the yeast Candida albicans can modulate and adapt to low oxygen levels in different body niches to cause infection and to harm the host. Studying adaption to hypoxic or anoxic niches is particularly fruitful, since it helps us to understand the ... more

CRISPR/Cas9 shown to limit impact of certain parasitic diseases

Limiting the impact of schistosomiasis and liver fluke infection

17-Jan-2019 For the first time, researchers at the George Washington University (GW), together with colleagues at institutes in Thailand, Australia, the U.K. and the Netherlands, and more, have successfully used the gene-editing tool CRISPR/Cas9 to limit the impact of parasitic worms responsible for sc ... more

Merck Welcomes Ten New Startups to its Innovation Center

17-Jan-2019 Merck announced the ten startups that will be joining the seventh intake of its Accelerator program at the Merck Innovation Center in Darmstadt. The teams come from nine different countries, making 2019 the most international intake in the Merck Accelerator’s history. They were chosen from ... more

Gaining control over soft-molecule synthesis

16-Jan-2019 By gaining control over shape, size and composition during synthetic molecule assembly, researchers can begin to probe how these factors influence the function of soft materials. Finding these answers could help advance virology, drug delivery development and the creation of new materials. ... more

Utilizing CRISPR for better antibiotics

Drug screening with Mobile-CRISPRi

15-Jan-2019 A University of Wisconsin-Madison researcher and his collaborators at the University of California, San Francisco have repurposed the gene-editing tool CRISPR to study which genes are targeted by particular antibiotics, providing clues on how to improve existing antibiotics or develop new o ... more

Adapting natural membrane to make hydrogen fuel from water

14-Jan-2019 A chemical reaction pathway central to plant biology have been adapted to form the backbone of a new process that converts water into hydrogen fuel using energy from the sun. In a recent study from the U.S. Department of Energy's (DOE) Argonne National Laboratory, scientists have combined t ... more

New fuel-delivery route for cells identified

Findings shed light on chronic diseases, aging

10-Jan-2019 Scientists at Washington University School of Medicine in St. Louis have identified a previously unknown route for cellular fuel delivery, a finding that could shed light on the process of aging and the chronic diseases that often accompany it. With age, cells gradually lose their ability t ... more

Green catalysts with Earth-abundant metals accelerate production of bio-based plastic

How crystalline structure can affect the performance of MnO2 catalysts

10-Jan-2019 Scientists at Tokyo Institute of Technology (Tokyo Tech) have developed and analyzed a novel catalyst for the oxidation of 5-hydroxymethyl furfural, which is crucial for generating new raw materials that replace the classic non-renewable ones used for making many plastics. It should be no s ... more

Faulty immune receptor could be reason why many face HIV complications

10-Jan-2019 For HIV patients, treatments that control the infection have come a long way. But many still struggle with a host of other disease-related complications such as neurocognitive disorders, cardiovascular issues, diabetes and chronic inflammation. Why these complications occur isn't exactly kn ... more

New materials could 'drive wound healing' by harnessing natural healing methods

09-Jan-2019 Materials are widely used to help heal wounds: Collagen sponges help treat burns and pressure sores, and scaffold-like implants are used to repair bones. However, the process of tissue repair changes over time, so scientists are developing biomaterials that interact with tissues as healing ... more

All news on biotechnology

Novel materials convert visible into infrared light

Penetrate of living tissue and other materials without damage by high-intensity light exposure

18-Jan-2019 Columbia University scientists, in collaboration with researchers from Harvard, have succeeded in developing a chemical process to convert visible light into infrared energy, allowing innocuous radiation to penetrate living tissue and other materials without the damage caused by high-intens ... more

New biomarker links cancer progression to genome instability

High level of specific protein in tumors indicates prognosis

14-Jan-2019 Our DNA is under constant attack. The delicate molecule that contains our genetic information is extremely vulnerable to everything from environmental agents, such as radiation, to the chemicals in the air we breathe and the food we eat. Genome instability can lead to genetic disorders, chr ... more

Speeding up genetic diagnosis of Huntington’s disease

11-Jan-2019 Elongated segments of DNA cause Huntington’s disease and certain other disorders of the brain. Researchers funded by the SNSF have developed a method to determine the length of the mutated genes quickly and easily. People with Huntington’s disease suffer from jerky body movements and decre ... more

Faulty immune receptor could be reason why many face HIV complications

10-Jan-2019 For HIV patients, treatments that control the infection have come a long way. But many still struggle with a host of other disease-related complications such as neurocognitive disorders, cardiovascular issues, diabetes and chronic inflammation. Why these complications occur isn't exactly kn ... more

Red meat allergy – who is ‘at steak’?

New test for a rare allergy

21-Dec-2018 Those who have the allergy exhibit symptoms two to six hours after consuming red meat – which includes beef, pork, lamb or game. So far, it has been possible to detect the disposition to develop allergic symptoms using a method involving special antibodies against alpha-gal and skin testing ... more

Prostate cancer – New computer model enables researchers to predict course of disease

18-Dec-2018 How does a normal cell turn into a deadly cancer? Seeking an answer to this question, and working alongside other international working groups, researchers from Charité – Universitätsmedizin Berlin examined the tumor genomes of nearly 300 prostate cancer patients. Their findings describe th ... more

Researchers lay foundation for smart contrast medium

Breakthrough in groundbreaking features in medical imaging

14-Dec-2018 Under the leadership of TU Graz, an international research team has developed a contrast medium concept for MRI, promising unprecedented features in medical imaging. Molecular imaging techniques are playing an increasingly important role in medical diagnostics and developing new treatment m ... more

Elevated hormone flags liver problems in mice with methylmalonic acidemia

Study findings can immediately be applied to human patients with the disease

11-Dec-2018 Researchers have discovered that a hormone, fibroblast growth factor 21 (FGF21), is extremely elevated in mice with liver disease that mimics the same condition in patients with methylmalonic acidemia (MMA), a serious genomic disorder. Based on this finding, medical teams treating patients ... more

Using graphene to detect ALS, other neurodegenerative diseases

06-Dec-2018 The wonders of graphene are numerous -- it can enable flexible electronic components, enhance solar cell capacity, filter the finest subatomic particles and revolutionize batteries. Now, the "supermaterial" may one day be used to test for amyotrophic lateral sclerosis, or ALS -- a progressi ... more

Classifying Alzheimer's patients in 6 subgroups

"Alzheimer's, like breast cancer, is not one disease" - Shubhabrata Mukherjee

06-Dec-2018 Researchers studying Alzheimer's disease have created an approach to classify patients with Alzheimer's disease, a finding that may open the door for personalized treatments. "Alzheimer's, like breast cancer, is not one disease," said lead author Shubhabrata Mukherjee, research assistant pr ... more

All news on diagnostics

Novel materials convert visible into infrared light

Penetrate of living tissue and other materials without damage by high-intensity light exposure

18-Jan-2019 Columbia University scientists, in collaboration with researchers from Harvard, have succeeded in developing a chemical process to convert visible light into infrared energy, allowing innocuous radiation to penetrate living tissue and other materials without the damage caused by high-intens ... more

LAUDA acquires laboratory specialist

18-Dec-2018 LAUDA DR. R. WOBSER GMBH & CO. KG has announced the acquisition of GFL Gesellschaft für Labortechnik mbH. This is the third takeover in total for the company from Lauda-Königshofen. While the previous acquisitions primarily served to open up new business areas in the industrial environment, ... more

denovoMATRIX receives seed financing

13-Dec-2018 denovoMATRIX develops and manufactures biomimetic coatings for stem cell culture. With its technology, the team of denovoMATRIX enables cutting edge research in the stem cell field, and aims to revolutionize cell culture processes in Life Science research. The HTGF together with TGFS are pa ... more

Sartorius Supervisory Board appoints two new Executive Board members

10-Dec-2018 The Supervisory Board of Sartorius AG resolved to make changes in the Executive Board. Effective January 1, 2019, Dr. René Fáber as Head of the Bioprocess Solutions Division and Gerry Mackay as Head of the Lab Products & Services Division will be appointed new members of the company’s Execu ... more

KÖTTERMANN finds an investor

06-Dec-2018 The investor process of the KÖTTERMANN® Group, as specialist for laboratory equipment “Made in Germany”, has been successfully completed. The insolvency administrator Dr. Christian Willmer from the law firm WILLMERKÖSTER and the BLOCK® Group have agreed on the takeover. A corresponding purc ... more

Biotage acquires PhyNexus

Strengthening position in lab-scale purification of biomolecules

04-Dec-2018 Biotage AB has entered into an agreement to acquire all outstanding shares in the privately held company PhyNexus, Inc. (PhyNexus) based in California, US, for a total purchase price of approx. USD 21.5 million  financed through a combination of newly issued shares in Biotage and existing c ... more

analytica Vietnam records exhibitor rush

29-Oct-2018 About half a year before the start of analytica Vietnam, the trade fair for laboratory technology, analysis, biotechnology and diagnostics in Ho Chi Minh City is in greater demand than ever before. Now, by the end of Octo-ber, about 60 percent more exhibitors than in the same period of 2016 ... more

Sartorius continues to grow by double digits

Growth dynamics of the Lab Products & Services Division impacted by softer European demand

24-Oct-2018 Sartorius continued on the growth track, with double-digit gains in sales revenue and earnings. “In the first nine months of 2018, Sartorius achieved excellent organic growth,” said Dr. Joachim Kreuzburg, Chief Executive Officer. “This applies particularly to the Bioprocess Solutions Divisi ... more

Miltenyi Biotec acquires microscopy specialist

18-Oct-2018 Miltenyi Biotec GmbH announced that it has acquired the high-end microscopy specialist LaVision BioTec GmbH. Located in Bielefeld, Germany, LaVision BioTec is a leading global specialist for advanced light-sheet and multiphoton microscopy solutions for life science applications. Since its f ... more

Liver-on-a-chip, the ideal test environment for CRISPR

16-Oct-2018 Two Arizona State University professors are among the first recipients ofSomatic Cell Genome Editing (SCGE) grants from the National Institutes of Health Common Fund. The $2,600,000, five-year grant will fund the first study of the genome editing technology CRISPR to be used on a "human liv ... more

All news on lab technology

Novel materials convert visible into infrared light

Penetrate of living tissue and other materials without damage by high-intensity light exposure

18-Jan-2019 Columbia University scientists, in collaboration with researchers from Harvard, have succeeded in developing a chemical process to convert visible light into infrared energy, allowing innocuous radiation to penetrate living tissue and other materials without the damage caused by high-intens ... more

SCHOTT to invest 300 million euros in pharmaceutical packaging business

Group to build new production facilities in Germany and China and expand capacity in India and Switzerland

18-Jan-2019 The SCHOTT technology group is set to invest around 300 million euros in the next three years in the expansion of its core business of glass tubing as the starting material for pharmaceutical packaging as well as pharmaceutical packaging made of glass and polymer, reinforcing its strong bel ... more

Merck Welcomes Ten New Startups to its Innovation Center

17-Jan-2019 Merck announced the ten startups that will be joining the seventh intake of its Accelerator program at the Merck Innovation Center in Darmstadt. The teams come from nine different countries, making 2019 the most international intake in the Merck Accelerator’s history. They were chosen from ... more

Utilizing CRISPR for better antibiotics

Drug screening with Mobile-CRISPRi

15-Jan-2019 A University of Wisconsin-Madison researcher and his collaborators at the University of California, San Francisco have repurposed the gene-editing tool CRISPR to study which genes are targeted by particular antibiotics, providing clues on how to improve existing antibiotics or develop new o ... more

Chirality in 'real-time'

Circular dichroism in the deep ultraviolet

11-Jan-2019 In nature, certain molecules with the same chemical composition, can exist in two different shapes that are mirrors images of each other, much like our hands. This property is known as "chirality" and molecules with different chirality are called enantiomers. Enantiomers can exhibit entirel ... more

QIAGEN acquires bioinformatics company

Expanding clinical bioinformatics capabilities in molecular oncology

08-Jan-2019 QIAGEN N.V. announced it has entered into an agreement to acquire N-of-One, Inc., a privately-held U.S. molecular decision support company and pioneer in clinical interpretation services for complex genomic data. The addition of N-of-One will enable QIAGEN to significantly expand its decisi ... more

Carrying and releasing nanoscale cargo with 'nanowrappers'

Nanocubes for biomedicine, catalysis and beyond

08-Jan-2019 This holiday season, scientists at the Center for Functional Nanomaterials (CFN)--a U.S. Department of Energy Office of Science User Facility at Brookhaven National Laboratory--have wrapped a box of a different kind. Using a one-step chemical synthesis method, they engineered hollow metalli ... more

Sanofi Invests EUR 80m in BioNTech

07-Jan-2019 BioNTech AG announced that it has extended its research collaboration with Sanofi initiated in late 2015 and Sanofi is investing* EUR 80 million (approximately USD 91.5 million) in equity in BioNTech. Simultaneously BioNTech has entered into an agreement with Sanofi to co-develop the first ... more

GlaxoSmithKline plc and Pfizer Inc to form new Consumer Healthcare Joint Venture

20-Dec-2018 GlaxoSmithKline plc has reached agreement with Pfizer Inc to combine their consumer health businesses into a new Joint Venture, with combined sales of approximately £9.8 billion ($12.7 billion). GSK will have a majority controlling equity interest of 68% and Pfizer will have an equity inter ... more

Lonza to Establish Strategic Biomanufacturing Base in China

13-Dec-2018 Lonza announced an agreement with GE Healthcare under which GE Healthcare will deliver a biologics facility to Lonza in Guangzhou (CN). As the facility is part of a larger biomanufacturing initiative between GE Healthcare and Guangzhou Development District (GDD), the agreement will be final ... more

All news on pharma

Deciphering diabetes with "game-changing" human blood vessels from stem cells

18-Jan-2019 Changes in blood vessels are the major cause of death and morbidity in diabetes. For the first time, scientists managed to grow perfect human blood vessels as organoids in a petri dish. This breakthrough engineering technology dramatically advances research of vascular dysfunction in diseas ... more

From gut to space

Candida albicans exploits lack of oxygen to cause disease

18-Jan-2019 Scientists from Umeå university have shown how the yeast Candida albicans can modulate and adapt to low oxygen levels in different body niches to cause infection and to harm the host. Studying adaption to hypoxic or anoxic niches is particularly fruitful, since it helps us to understand the ... more

CRISPR/Cas9 shown to limit impact of certain parasitic diseases

Limiting the impact of schistosomiasis and liver fluke infection

17-Jan-2019 For the first time, researchers at the George Washington University (GW), together with colleagues at institutes in Thailand, Australia, the U.K. and the Netherlands, and more, have successfully used the gene-editing tool CRISPR/Cas9 to limit the impact of parasitic worms responsible for sc ... more

Engineered T cells promote long-term organ transplant acceptance

16-Jan-2019 Organ transplant rejection is a major problem in transplantation medicine. Suppressing the immune system to prevent organ rejection, however, opens the door to life-threatening infections. Researchers at the University of Basel’s Biozentrum have now discovered a molecular approach preventin ... more

Conversion of breast cancer cells into fat cells impedes the formation of metastases

16-Jan-2019 An innovative combination therapy can force malignant breast cancer cells to turn into fat cells. This can be used to prevent the formation of metastases in mice, as researchers at the University of Basel’s Department of Biomedicine recently reported in the journal Cancer Cell. Tumor cells ... more

Potential for risky behavior is also in your genes

15-Jan-2019 As part of an international research project, a group of scientists from the University of Zurich found genetic variants associated with risk tolerance and risky behaviors. It is one of the first studies to link genetic variants with behavioral outcomes, which are relevant to social science ... more

Utilizing CRISPR for better antibiotics

Drug screening with Mobile-CRISPRi

15-Jan-2019 A University of Wisconsin-Madison researcher and his collaborators at the University of California, San Francisco have repurposed the gene-editing tool CRISPR to study which genes are targeted by particular antibiotics, providing clues on how to improve existing antibiotics or develop new o ... more

Do some prescriptive sleeping pills posses a danger?

Novel class of sleeping pills might prevent ability to wake in response to threat

15-Jan-2019 In a trial of one of the main class of prescription sleeping pills, half the participants slept through a fire alarm as loud as someone vacuuming next to their bed. But a newer alternative preserves the ability to wake in response to danger signals, according to a new research. The study sh ... more

New biomarker links cancer progression to genome instability

High level of specific protein in tumors indicates prognosis

14-Jan-2019 Our DNA is under constant attack. The delicate molecule that contains our genetic information is extremely vulnerable to everything from environmental agents, such as radiation, to the chemicals in the air we breathe and the food we eat. Genome instability can lead to genetic disorders, chr ... more

A drug against the formation of metastasis

14-Jan-2019 The most deadly aspect of breast cancer is metastasis. It spreads cancer cells throughout the body. Researchers at the University and the University Hospital of Basel have now discovered a substance that suppresses the formation of metastases. In the journal Cell, the team of molecular biol ... more

All news on healthcare
News by department
  • Products

    Atriva Therapeutics announces first closing of series A financing round

    04-Jan-2019 Atriva Therapeutics, a biopharmaceutical company pioneering the development of host-targeting antiviral therapies, announced the first closing in its ongoing series A financing round lead by Meneldor and High-Tech Gründerfonds (HTGF). The Company founders and management joined the round, al ... more

    Merck Announces FDA Orphan Drug Designation for Bifunctional Immunotherapy

    12-Dec-2018 Merck announced that the US Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to M7824, the first regulatory designation for the bifunctional immunotherapy, for the treatment of biliary tract cancer (BTC). The FDA orphan drug designation follows the recent present ... more

    Camel-IDS EUR 37m Series A financing led by V-Bio Ventures

    Life Science company to develop cancer targeted radiopharmaceuticals

    16-Nov-2018 Camel-IDS, a VUB spin-off company developing cancer-targeted radiopharmaceuticals, today secured EUR 37m in a Series A investment round led by V-Bio Ventures (Belgium) and Gimv (Belgium), joined by the co-lead investors HealthCap (Sweden), Novo Seeds (Denmark), Pontifax (Israel) and BioMedP ... more

  • Business

    SCHOTT to invest 300 million euros in pharmaceutical packaging business

    Group to build new production facilities in Germany and China and expand capacity in India and Switzerland

    18-Jan-2019 The SCHOTT technology group is set to invest around 300 million euros in the next three years in the expansion of its core business of glass tubing as the starting material for pharmaceutical packaging as well as pharmaceutical packaging made of glass and polymer, reinforcing its strong bel ... more

    Merck Welcomes Ten New Startups to its Innovation Center

    17-Jan-2019 Merck announced the ten startups that will be joining the seventh intake of its Accelerator program at the Merck Innovation Center in Darmstadt. The teams come from nine different countries, making 2019 the most international intake in the Merck Accelerator’s history. They were chosen from ... more

    QIAGEN acquires bioinformatics company

    Expanding clinical bioinformatics capabilities in molecular oncology

    08-Jan-2019 QIAGEN N.V. announced it has entered into an agreement to acquire N-of-One, Inc., a privately-held U.S. molecular decision support company and pioneer in clinical interpretation services for complex genomic data. The addition of N-of-One will enable QIAGEN to significantly expand its decisi ... more

  • Price Development

    Drug costs vary by more than 600% in study of 10 high-income countries

    13-Jun-2017 In a study of 10 high-income countries with universal health care, costs for prescription drugs in 6 of the largest categories of primary care medicines varied by more than 600%. All countries except Canada offered universal coverage of outpatient prescription drugs. The study looked at dat ... more

    Cell Medica granted Orphan Drug designation for novel cellular therapy

    18-Mar-2015 Cell Medica announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to the company’s cancer immunotherapy treatment, referred to as CMD-003, under development for Epstein-Barr Virus (EBV) positive non-Hodgkin lymphomas. Additionally, the company announ ... more

    BASF increases prices for Vitamin E and A feed grade

    14-Nov-2013 BASF increases prices for Vitamin E and A products for animal nutrition globally and with immediate effect. Prices will increase by 15% for all Vitamin E products and by 10% for all Vitamin A products. Existing contractual obligations with customers will be honored. more

  • Research

    Deciphering diabetes with "game-changing" human blood vessels from stem cells

    18-Jan-2019 Changes in blood vessels are the major cause of death and morbidity in diabetes. For the first time, scientists managed to grow perfect human blood vessels as organoids in a petri dish. This breakthrough engineering technology dramatically advances research of vascular dysfunction in diseas ... more

    Novel materials convert visible into infrared light

    Penetrate of living tissue and other materials without damage by high-intensity light exposure

    18-Jan-2019 Columbia University scientists, in collaboration with researchers from Harvard, have succeeded in developing a chemical process to convert visible light into infrared energy, allowing innocuous radiation to penetrate living tissue and other materials without the damage caused by high-intens ... more

    From gut to space

    Candida albicans exploits lack of oxygen to cause disease

    18-Jan-2019 Scientists from Umeå university have shown how the yeast Candida albicans can modulate and adapt to low oxygen levels in different body niches to cause infection and to harm the host. Studying adaption to hypoxic or anoxic niches is particularly fruitful, since it helps us to understand the ... more

  • People

    PerkinElmer appoints President & Chief Operating Officer

    12-Dec-2018 PerkinElmer announced that its board of directors has named Prahlad Singh president and chief operating officer, effective January 1, 2019. In his expanded position, Dr. Singh will have responsibility for both the Discovery and Analytical Solutions (DAS) and Diagnostics operating divisions ... more

    Sartorius Supervisory Board appoints two new Executive Board members

    10-Dec-2018 The Supervisory Board of Sartorius AG resolved to make changes in the Executive Board. Effective January 1, 2019, Dr. René Fáber as Head of the Bioprocess Solutions Division and Gerry Mackay as Head of the Lab Products & Services Division will be appointed new members of the company’s Execu ... more

    Abzena invests in expansion of biotherapeutics and makes executive appointment

    07-Nov-2018 Dr. Jonathan Goldman, CEO, announced that Abzena has augmented existing 500 L scale biologics equipment with $20M of investment into two new manufacturing suites at 500 L and 2000 L scale in a new GMP facility in San Diego, which will be equipped with Sartorius single use bioreactors. Abzen ... more

  • Finances

    QIAGEN acquires bioinformatics company

    Expanding clinical bioinformatics capabilities in molecular oncology

    08-Jan-2019 QIAGEN N.V. announced it has entered into an agreement to acquire N-of-One, Inc., a privately-held U.S. molecular decision support company and pioneer in clinical interpretation services for complex genomic data. The addition of N-of-One will enable QIAGEN to significantly expand its decisi ... more

    Atriva Therapeutics announces first closing of series A financing round

    04-Jan-2019 Atriva Therapeutics, a biopharmaceutical company pioneering the development of host-targeting antiviral therapies, announced the first closing in its ongoing series A financing round lead by Meneldor and High-Tech Gründerfonds (HTGF). The Company founders and management joined the round, al ... more

    Relay Therapeutics Secures $400 Million in Series C Financing

    21-Dec-2018 Relay Therapeutics, a new breed of company at the intersection of computation and biotechnology, announced the successful completion of a $400 million Series C financing. Relay Therapeutics combines unprecedented computational power with leading-edge experimental approaches across the field ... more

  • Cooperation

    Sanofi Invests EUR 80m in BioNTech

    07-Jan-2019 BioNTech AG announced that it has extended its research collaboration with Sanofi initiated in late 2015 and Sanofi is investing* EUR 80 million (approximately USD 91.5 million) in equity in BioNTech. Simultaneously BioNTech has entered into an agreement with Sanofi to co-develop the first ... more

    Oculyze & BIOTECON Diagnostics sign strategic partnership

    18-Dec-2018 Oculyze and BIOTECON Diagnostics announced the signing of a strategic partnership. The agreement signed at the corporate offices of BIOTECON Diagnostics in Potsdam, appoints the Company as the exclusive global distributor of Oculyze’s latest technological innovation the Oculyze Better Brewi ... more

    Evotec and LEO Pharma form drug discovery alliance targeting dermatological conditions

    05-Dec-2018 Evotec AG announced a new integrated drug discovery alliance with LEO Pharma. The collaboration goal is to generate new leads against innovative targets for a range of dermatological conditions and initially runs for two years. The collaboration leverages Evotec’s industry-leading hit ident ... more

  • Technology

    Novel materials convert visible into infrared light

    Penetrate of living tissue and other materials without damage by high-intensity light exposure

    18-Jan-2019 Columbia University scientists, in collaboration with researchers from Harvard, have succeeded in developing a chemical process to convert visible light into infrared energy, allowing innocuous radiation to penetrate living tissue and other materials without the damage caused by high-intens ... more

    From gut to space

    Candida albicans exploits lack of oxygen to cause disease

    18-Jan-2019 Scientists from Umeå university have shown how the yeast Candida albicans can modulate and adapt to low oxygen levels in different body niches to cause infection and to harm the host. Studying adaption to hypoxic or anoxic niches is particularly fruitful, since it helps us to understand the ... more

    CRISPR/Cas9 shown to limit impact of certain parasitic diseases

    Limiting the impact of schistosomiasis and liver fluke infection

    17-Jan-2019 For the first time, researchers at the George Washington University (GW), together with colleagues at institutes in Thailand, Australia, the U.K. and the Netherlands, and more, have successfully used the gene-editing tool CRISPR/Cas9 to limit the impact of parasitic worms responsible for sc ... more

  • Laws

    ECETOC Task Force provides new insights

    Toxicity testing of microparticles and poorly soluble liquids in the water environment

    15-Jan-2019 A Task Force set up by the European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC) has provided new insights into scientific testing for the impact of undissolved particles in the aquatic environment. ECETOC launched the Task Force in response to increasing concerns among the ... more

    Opening the way for global innovation in biotechnology

    New agreement supports sharing, innovation and openness

    16-Oct-2018 A new easy-to-use legal tool that enables open exchange of biological materials is launched. The OpenMTA is a Material Transfer Agreement (MTA) designed to support openness, sharing and innovation in global biotechnology. Material Transfer Agreements (MTAs) provide the legal frameworks with ... more

    Recipharm releases first serialised products to Europe

    12-Oct-2018 Recipharm has released its first serialised products to Europe from its facilities in Lisbon, Portugal and Stockholm, Sweden. In 2016 Recipharm committed to invest 40 million euros in preparing its facilities for the European Falsified Medicines Directive (EU FMD). The release of its first ... more

  • Market

    Lonza to Establish Strategic Biomanufacturing Base in China

    13-Dec-2018 Lonza announced an agreement with GE Healthcare under which GE Healthcare will deliver a biologics facility to Lonza in Guangzhou (CN). As the facility is part of a larger biomanufacturing initiative between GE Healthcare and Guangzhou Development District (GDD), the agreement will be final ... more

    SOPAT GmbH and Malvern Panalytical announce a distribution agreement for US market

    09-Oct-2018 SOPAT GmbH announced a distribution agreement with Malvern Panalytical. Malvern Panalytical is now the exclusive distributor for a complete range of SOPAT photo-optical image analysis instrumentation and software in the United States of America. “We are thrilled to be working together with ... more

    Catalent Invests $7.3 Million in Italy

    Expands Softgel Encapsulation and Packaging Capabilities in Support of Consumer Health

    08-Oct-2018 Catalent Pharma Solutions announced that it had completed the first phase of a $7.3 million investment to upgrade and expand its packaging and softgel encapsulation capabilities at its facility in Aprilia, Italy. The first phase of investment, completed in August 2018, saw the expansion and ... more

  • Politics

    ECETOC Task Force provides new insights

    Toxicity testing of microparticles and poorly soluble liquids in the water environment

    15-Jan-2019 A Task Force set up by the European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC) has provided new insights into scientific testing for the impact of undissolved particles in the aquatic environment. ECETOC launched the Task Force in response to increasing concerns among the ... more

    15 emerging technologies that could reduce global catastrophic biological risks

    11-Oct-2018 Strategic investment in 15 promising technologies could help make the world better prepared and equipped to prevent future infectious disease outbreaks from becoming catastrophic events. This subset of emerging technologies and their potential application are the focus of a new report, Tech ... more

    The starch risk to teeth

    08-Aug-2018 An examination of research on oral health, commissioned by the World Health Organisation, has indicated that for oral health we should stick to whole grain carbohydrates and avoid processed ones, especially if sweet. Food contains different types of starchy carbohydrate with varying degrees ... more

  • Manufacturing

    SCHOTT to invest 300 million euros in pharmaceutical packaging business

    Group to build new production facilities in Germany and China and expand capacity in India and Switzerland

    18-Jan-2019 The SCHOTT technology group is set to invest around 300 million euros in the next three years in the expansion of its core business of glass tubing as the starting material for pharmaceutical packaging as well as pharmaceutical packaging made of glass and polymer, reinforcing its strong bel ... more

    Lonza to Establish Strategic Biomanufacturing Base in China

    13-Dec-2018 Lonza announced an agreement with GE Healthcare under which GE Healthcare will deliver a biologics facility to Lonza in Guangzhou (CN). As the facility is part of a larger biomanufacturing initiative between GE Healthcare and Guangzhou Development District (GDD), the agreement will be final ... more

    Eisai commences full-scale operation of new production site

    Strengthening in-house domestic production system in China

    09-Nov-2018 Eisai Co., Ltd. announced that its Chinese subsidiary, Eisai China Inc. (ECI) has commenced full-scale operation of its new Suzhou plant located within the Suzhou Industrial Park, and an opening ceremony was held accordingly. Aiming to further expand its contribution to patients in China, E ... more

  • Career

    Agilent and University of Duisburg-Essen Announce Collaboration Agreement

    New Teaching and Research Center for Separation

    28-May-2018 Agilent Technologies Inc. and the University of Duisburg-Essen has formed a collaboration agreement that brings together Agilent's leading analytical technologies with the University's outstanding researchers. As part of the collaboration, Agilent will support the university with a broad ra ... more

    Systematic analysis of data from animal models reveals opportunities and limitations

    Professor Malcolm Macleod awarded the BfR’s Maria Sibylla Merian Fellowship

    18-Apr-2018 What opportunities and what limits result from the use of laboratory animals in the preclinical and clinical research? Neurologist Malcolm Macleod has dedicated himself to this topic. For his interdisciplinary research work and his contribution to improving animal welfare, he is awarded thi ... more

    Sartorius Stedim supports biotech training at U Penn

    17-Apr-2018 Sartorius Stedim Biotech andPenn State University have entered into a collaborative partnership to advance multidisciplinary teaching and research in biotechnology. This long-term relationship will support the education and preparation of the next generation of biotechnology leaders. Part o ... more

News according to country
News archive
Newsletters

bionity.com Newsletter

The bionity.com newsletter keeps you informed about the current events in the fields of biotechnology, life sciences and medicine with news, products, company profiles and technical information.
Current edition

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE